The induced membrane forms a vascularized chamber around the spacer, creating a protected environment for later graft placement. After maturation, it helps retain the graft within the defect and releases signaling factors associated with vascularization and bone formation. These properties connect the local tissue response to the regenerative phase rather than treating the defect as an empty mechanical space.
The PMMA spacer serves as a local antibiotic-delivery material while occupying the bone defect during the first stage. Its placement follows removal of nonviable or infected tissue, so antibiotic exposure occurs within a surgically cleaned region. This combination links structural space maintenance with efforts to control infection before definitive grafting is considered.
The two-stage sequence separates infection management from regenerative reconstruction. Surgeons wait until infection is controlled and the surrounding membrane has matured before removing the spacer and adding graft. This timing preserves the membrane’s protective and biologically supportive role, allowing the second stage to use a prepared chamber rather than introducing graft into an unresolved infected or immature site.
The first stage begins with debridement, meaning removal of nonviable or infected tissue from the defect. Surgeons then place an antibiotic-loaded polymethyl methacrylate spacer into the cleared region. The spacer supports local antibiotic delivery and becomes the structure around which the body develops the vascularized membrane needed for the later reconstruction stage.
Once infection control and membrane maturation have been achieved, surgeons remove the PMMA spacer and fill the resulting cavity with bone graft. The preformed membrane helps contain that graft and provides signaling factors associated with vascularization and bone formation. Consequently, the second operation uses both a physical chamber and a biologically active tissue environment.
This technique provides a model in which infection control, local antibiotic delivery, tissue response, and bone regeneration occur within one staged treatment strategy. Its relevance to immunology and infection lies in examining how a surgically created, vascularized membrane supports repair after infected or severely damaged tissue has been addressed. It therefore connects antimicrobial management with regenerative outcomes.